These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 11294032)

  • 1. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J; Teppa-Garrán AD
    Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian disease and congenital and late-onset adrenal hyperplasia.
    New MI
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):637-48. PubMed ID: 3058471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adrenal cortex and virilization.
    McKenna TJ; Cunningham SK; Loughlin T
    Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Lobo RA
    Fertil Steril; 1996 Sep; 66(3):354-61. PubMed ID: 8751729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B; Tworowska U; Demissie M; Milewicz A
    Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
    J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of functional ovarian hyperandrogenism in women with androgen excess.
    Ehrmann DA; Rosenfield RL; Barnes RB; Brigell DF; Sheikh Z
    N Engl J Med; 1992 Jul; 327(3):157-62. PubMed ID: 1319000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
    Kondoh Y; Uemura T; Ishikawa M; Yokoi N; Hirahara F
    Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian disease.
    Gindoff PR; Jewelewicz R
    Obstet Gynecol Clin North Am; 1987 Dec; 14(4):931-53. PubMed ID: 3328131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disorders of steroid hormone synthesis and metabolism.
    New MI; White PC
    Baillieres Clin Endocrinol Metab; 1995 Jul; 9(3):525-54. PubMed ID: 7575331
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical approach to the diagnosis of polycystic ovary syndrome.
    Chang RJ
    Am J Obstet Gynecol; 2004 Sep; 191(3):713-7. PubMed ID: 15467530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.